2 completed, 1 withdrawn. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
Follow BiomX, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection BX004-A, Placebo - Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis | Phase 1 / Phase 2 | Completed | BiomX, Inc. | 43 | 2022-06-21 | 2025-07-18 |
| A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis BX005-A, Placebo - Atopic Dermatitis | Phase 1 / Phase 2 | Withdrawn | BiomX, Inc. | 2022-05-01 | 2025-08-03 | |
| A Study to Evaluate the Safety, Tolerability, and Fecal Pharmacokinetics of BX002-A in Healthy Adults BX002-A, Placebo - Healthy Volunteers | Phase 1 | Completed | BiomX, Inc. | 18 | 2020-10-28 | 2022-01-25 |
Cystic Fibrosis (1) · Dermatitis, Atopic (1)
United States (2) · Czechia (1) · Israel (1) · Netherlands (1) · Spain (1)
Urania Rappo, MD (2)